SPDR® S&P Health Care Equipment ETF
Brazil’s medical device industry: Health coverage outlook
The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.
Tandem Diabetes Care Stock Has Skyrocketed in 2018
On November 21, Tandem Diabetes Care stock closed at $32.63, a ~14.69% rise from its previous day’s close of $28.45.
Haemonetics’s Fiscal Q1 Earnings Surpass Analyst Estimates
Haemonetics reported an 8.7% YoY increase in revenues to $229.3 million during Q1 2019 as compared to revenues of $210.9 million during Q1 2018.
What Analysts Expect from Haemonetics in Q1 2019
Haemonetics is expected to report 4.3% growth in revenues to $219.9 million during Q1 2019 as compared to $210.9 million during Q1 2018.
Exploring Antares Pharma’s Current Pipeline of Products
On October 11, 2017, Antares Pharma (ATRS) was notified by the FDA that it had found deficiencies in Xyosted.
What Analysts Are Recommending for Dentsply Sirona
According to the recommendations of 15 brokerage firms, 60.0% (or nine) of them have rated Dentsply Sirona (XRAY) a “buy,” and 33.0% (or five) have rated it a “hold.”
What Do Analysts Recommend for Dentsply Sirona?
Based on the recommendations of 16 brokerage companies, around 63% (or ten) of the analysts provided a “buy” recommendation for Dentsply Sirona.
Are Covidien’s layoffs good for the medical device industry?
Covidien (COV) announced that it will lay off a significant amount of employees as part of global restructuring efforts. The initiative aims to save the company up to $300 million a year by fiscal 2018.
Why the medical device tax repeal bill shouldn’t pass anytime soon
The proposed Protect Medical Innovation Act of 2013 The Protect Medical Innovation Act of 2013 has gained bi-partisan support in the House of Representatives, ensuring the bill passes when it comes to vote. But the keyword is “when” it comes to vote. Witnessing large layoffs by companies like Stryker Corp. in November 2012, lawmakers began taking […]